Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Senti Biosciences Holdings, Inc. (NASDAQ: SNTI)
SNTI Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-52.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
SNTI Stock Analysis
SNTI
PE Ratio:
SNTI
PEG Ratio:
Not Available
SNTI
Forward EPS Growth (12 month):
0.00%
SNTI
PS Ratio:
674.8
SNTI
PSG Ratio:
Not Available
SNTI
Forward Revenue Growth (12 month):
0.00%
SNTI Articles
No data was found